Correlation Between Kymera Therapeutics and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Passage Bio, you can compare the effects of market volatilities on Kymera Therapeutics and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Passage Bio.
Diversification Opportunities for Kymera Therapeutics and Passage Bio
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Kymera and Passage is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Passage Bio go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Passage Bio
Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 0.82 times more return on investment than Passage Bio. However, Kymera Therapeutics is 1.22 times less risky than Passage Bio. It trades about 0.05 of its potential returns per unit of risk. Passage Bio is currently generating about 0.0 per unit of risk. If you would invest 2,752 in Kymera Therapeutics on August 28, 2024 and sell it today you would earn a total of 1,950 from holding Kymera Therapeutics or generate 70.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kymera Therapeutics vs. Passage Bio
Performance |
| Timeline |
| Kymera Therapeutics |
| Passage Bio |
Kymera Therapeutics and Passage Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kymera Therapeutics and Passage Bio
The main advantage of trading using opposite Kymera Therapeutics and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
| Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |